2019
DOI: 10.1002/cam4.2122
|View full text |Cite
|
Sign up to set email alerts
|

DNA alteration‐based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high‐risk group

Abstract: Background In uveal melanomas, immune infiltration is a marker of poor prognosis. This work intended to decipher the biological characteristics of intra‐tumor immune population, compare it to other established biomarkers and to patients' outcome. Methods Primary, untreated, and mainly large uveal melanomas with retinal detachment were analyzed using: transcriptomic profiling (n = 15), RT‐qPCR (n = 36), immunohistochemistry (n = 89), Multiplex Ligation‐dependent Probe Amplification (MLPA) for copy number altera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 35 publications
0
10
0
Order By: Relevance
“…While our results need further verification in different experimental settings, the CIBERSORTx algorithm we employed has been extensively validated with techniques such as flow cytometry, mass cytometry, immunohistochemistry, and single-cell RNA-seq by multiple different groups, providing robust data confirming its accuracy [40,[63][64][65]. Nevertheless, others have already created mRNA/miRNA/DNA-based scores with strong prognostic values in UM tumors [33,[66][67][68][69][70][71][72]. Rather than compete with them, our foremost motive for creating the cell type-based prognostic score was to select the cell types playing a prime role in the biology of UM progression Previous research has identified extensive lymphocyte infiltration as a negative prognostic factor in UM; however, the prognostic role of individual subsets was not assessed Another dominant subset of tumor-infiltrating immune cells is macrophages.…”
Section: Journal Of Immunology Researchmentioning
confidence: 75%
“…While our results need further verification in different experimental settings, the CIBERSORTx algorithm we employed has been extensively validated with techniques such as flow cytometry, mass cytometry, immunohistochemistry, and single-cell RNA-seq by multiple different groups, providing robust data confirming its accuracy [40,[63][64][65]. Nevertheless, others have already created mRNA/miRNA/DNA-based scores with strong prognostic values in UM tumors [33,[66][67][68][69][70][71][72]. Rather than compete with them, our foremost motive for creating the cell type-based prognostic score was to select the cell types playing a prime role in the biology of UM progression Previous research has identified extensive lymphocyte infiltration as a negative prognostic factor in UM; however, the prognostic role of individual subsets was not assessed Another dominant subset of tumor-infiltrating immune cells is macrophages.…”
Section: Journal Of Immunology Researchmentioning
confidence: 75%
“…One recent study has demonstrated that loss of BAP1 expression is strongly associated with immune modulation of the microenvironment, and it makes an impact on the immunotherapy of UM [35]. Furthermore, Narasimhaiah et al found that immune cell infiltration was associated with poorer outcomes in the intermediate-risk group and increased in the high-risk group, indicating that immune infiltration may be a promising biomarker repository for better-personalized management of UM [10]. Our research on genes involved in the microenvironment of UM provides an opportunity for the development of therapeutic agents or gene targets.…”
Section: Plos Onementioning
confidence: 99%
“…Narasimhaiah and colleagues found that UM with IFNγ-signature had a poorer prognosis and showed increased infiltration of CD8+ T lymphocytes and macrophages. In UM, it was demonstrated that immune cell infiltration was associated with poorer outcomes in the intermediate-risk group and increased in high-risk group (73.7%) [10]. ESTIMATE, designed by Yoshihara et al, is a tool for predicting tumor purity, and the presence of infiltrating stromal/immune cells in tumor tissues using gene expression data [11].…”
Section: Introductionmentioning
confidence: 99%
“…Notably, SLCO5A1 was considered as a prognosis gene correlated with the immune infiltrates. The immune cell infiltration level was noted to be a crucial factor in predicting the UM prognosis ( 33 ). Supplementally, we sought out that BAP1 was associated with abnormal DNA methylation within IntSub2 samples rather than other subtypes.…”
Section: Resultsmentioning
confidence: 99%